Compare TMDX & MATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | MATX |
|---|---|---|
| Founded | 1998 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.0B |
| IPO Year | 2019 | N/A |
| Metric | TMDX | MATX |
|---|---|---|
| Price | $129.52 | $158.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $144.25 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 753.2K | 325.5K |
| Earning Date | 02-24-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 0.88% |
| EPS Growth | ★ 170.70 | 10.58 |
| EPS | 2.54 | ★ 13.11 |
| Revenue | $566,354,000.00 | ★ $3,382,900,000.00 |
| Revenue This Year | $38.73 | N/A |
| Revenue Next Year | $20.55 | $2.73 |
| P/E Ratio | $52.56 | ★ $12.42 |
| Revenue Growth | ★ 41.20 | 1.88 |
| 52 Week Low | $62.07 | $86.97 |
| 52 Week High | $156.00 | $169.20 |
| Indicator | TMDX | MATX |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 60.08 |
| Support Level | $127.00 | $158.23 |
| Resistance Level | $140.72 | $163.78 |
| Average True Range (ATR) | 6.68 | 4.87 |
| MACD | -0.70 | -1.41 |
| Stochastic Oscillator | 13.23 | 28.28 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Matson Inc is engaged in providing ocean transportation and logistics services. The business segments of the company are Ocean Transportation which provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific, and Logistics segment which offers long haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.